Search results

Views of the ethical treatment of persons with disabilities are changing rapidly. The fervently held goals of yesterday are often the rejected status quo of today. Bringing together behavioral psychologists, physicians, consumers, and advocates, this book deals with how things ought to be for persons with developmental disabilities. If you work with persons who have disabilities, you need this book.

AbstractTechnical analysis (TA) is used in evaluating its predictive power for the Morgan Stanley Capital International (MSCI) Emerging Market Index (EMI) that reflects 23 emerging market economies' equity indices. We conclude strong predictive power of technical analysis for the EMI. Given this predictive power of TA, we then investigate whether investors can exploit this predictive power to beat the profitability of the Buy‐and‐Hold strategy considering both risk and transaction costs. Applying Moving Average, Relative Strength Index, Moving Average Convergence Divergence, and Rate of Change trading rules to the MSCI Emerging Market Index over the period of 11/1/1988 to 5/1/2017 reveals strong empirical evidence that investors could use TA to out‐perform the Buy‐and‐Hold strategy even when considering risk and transaction costs. This research provides evidence against the Efficient Market Hypothesis for EMI.

PurposeIndividuals' health is considered one of the major determinants of higher levels of productivity and economic development. Over the past century, the widespread occurrence of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) has been a serious threat to economic development around the globe and has caused a dramatic fall in the life expectancy rate in many nations. This is the first study that examines the impact of HIV prevalence on health expenditure at the national level employing two linear and nonlinear autoregressive distributed lag (ARDL) models and simultaneously tests the long-run and short-run relationship for five selected developed countries. The authors employ annual data from 1981 to 2016. They find that HIV prevalence has a significant impact on health expenditure in the short-run and long-run in all five countries using the linear model and four of the countries in the nonlinear model. They find that HIV/AIDS prevalence has a significant short-run and long-run asymmetric impact on health expenditure of almost all selected developed economies.Design/methodology/approachThe authors are employing two linear and nonlinear ARDL models and simultaneously test the long-run and short-run relationship for five selected developed countries.FindingsThe authors find that HIV/AIDS prevalence has a significant short-run and long-run asymmetric impact on health expenditure of almost all selected developed economies.Originality/valueTo the best of the authors' knowledge, this is the first research work that empirically examines the link between HIV prevalence and health expenditure for this group of countries using linear and nonlinear ARDL approach for short run and long run.